120 related articles for article (PubMed ID: 22115282)
1. An elevated level of TSH might be predictive of differentiated thyroid cancer.
Dorange A; Triau S; Mucci-Hennekinne S; Bizon A; Laboureau-Soares S; Illouz F; Rodien P; Rohmer V
Ann Endocrinol (Paris); 2011 Dec; 72(6):513-21. PubMed ID: 22115282
[TBL] [Abstract][Full Text] [Related]
2. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
Zafón C; Obiols G; Mesa J
Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
[TBL] [Abstract][Full Text] [Related]
3. [Association between the serum TSH concentration and thyroid cancer incidence].
Li JZ; Jin YJ; Liu X; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):921-4. PubMed ID: 22340102
[TBL] [Abstract][Full Text] [Related]
4. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
[TBL] [Abstract][Full Text] [Related]
6. Serum thyrotropin concentration in children with isolated thyroid nodules.
Mussa A; Salerno MC; Bona G; Wasniewska M; Segni M; Cassio A; Vigone MC; Gastaldi R; Iughetti L; Santanera A; Capalbo D; Matarazzo P; De Luca F; Weber G; Corrias A
J Pediatr; 2013 Nov; 163(5):1465-70. PubMed ID: 23972643
[TBL] [Abstract][Full Text] [Related]
7. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer.
Pujol P; Daures JP; Nsakala N; Baldet L; Bringer J; Jaffiol C
J Clin Endocrinol Metab; 1996 Dec; 81(12):4318-23. PubMed ID: 8954034
[TBL] [Abstract][Full Text] [Related]
8. Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study.
Golbert L; de Cristo AP; Faccin CS; Farenzena M; Folgierini H; Graudenz MS; Maia AL
PLoS One; 2017; 12(11):e0188123. PubMed ID: 29145466
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin serum concentrations in patients with papillary thyroid microcancers.
Gerschpacher M; Göbl C; Anderwald C; Gessl A; Krebs M
Thyroid; 2010 Apr; 20(4):389-92. PubMed ID: 20210672
[TBL] [Abstract][Full Text] [Related]
10. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.
Kamel N; Güllü S; Dağci Ilgin S; Corapçioğlu D; Tonyukuk Cesur V; Uysal AR; Başkal N; Erdoğan G
Thyroid; 1999 Dec; 9(12):1245-8. PubMed ID: 10646665
[TBL] [Abstract][Full Text] [Related]
11. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
Perticone F; Pigliaru F; Mariotti S; Deiana L; Furlani L; Mortini P; Losa M
Thyroid; 2015 Apr; 25(4):417-24. PubMed ID: 25647054
[TBL] [Abstract][Full Text] [Related]
12. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
[TBL] [Abstract][Full Text] [Related]
13. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.
Jonklaas J; Nsouli-Maktabi H; Soldin SJ
Thyroid; 2008 Sep; 18(9):943-52. PubMed ID: 18788918
[TBL] [Abstract][Full Text] [Related]
14. Preoperative TSH and thyroglobulin levels: would it predict thyroid cancer?
Al-Bader A; Zawawi F; Singer Z; Mlynarek A; Hier M; Tamilia M; Payne R
Otolaryngol Pol; 2015; 69(3):21-5. PubMed ID: 26388246
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
Cooper DS; Specker B; Ho M; Sperling M; Ladenson PW; Ross DS; Ain KB; Bigos ST; Brierley JD; Haugen BR; Klein I; Robbins J; Sherman SI; Taylor T; Maxon HR
Thyroid; 1998 Sep; 8(9):737-44. PubMed ID: 9777742
[TBL] [Abstract][Full Text] [Related]
16. The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease.
Jin J; Machekano R; McHenry CR
Am J Surg; 2010 Mar; 199(3):294-7; discussion 298. PubMed ID: 20226898
[TBL] [Abstract][Full Text] [Related]
17. Correlation of TSH with the risk of paediatric thyroid carcinoma.
Chiu HK; Sanda S; Fechner PY; Pihoker C
Clin Endocrinol (Oxf); 2012 Aug; 77(2):316-22. PubMed ID: 22404106
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal therapy in differentiated carcinoma of the thyroid gland].
Francia G; Davì MV; Petroziello A; Sussi PL
Chir Ital; 1994; 46(4):56-8. PubMed ID: 7882445
[TBL] [Abstract][Full Text] [Related]
19. Risk of malignancy in follicular thyroid neoplasm: predictive value of thyrotropin.
Zimny M; Selkinski I; Blasius S; Rink T; Schroth HJ; Grünwald F
Nuklearmedizin; 2012; 51(4):119-24. PubMed ID: 22526481
[TBL] [Abstract][Full Text] [Related]
20. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
